HYDERABAD, India, June 4, 2024 /PRNewswire/ -- AmpleLogic, a leading provider of GAMP solutions, announces the launch of its revolutionary Application Platform as a Service (aPaaS) designed specifically for the life sciences sector. This cutting-edge platform leverages low-code/no-code technology to accelerate digitization in life sciences industry while enhancing operational efficiency and ensuring compliance with regulatory standards from USFDA, MHRA, EMEA, ISO, and GAMP guidelines.

AmpleLogic's aPaaS platform offers a unique Build Your Own Application (BYOA) feature, enabling companies to quickly respond to emerging regulatory requirements and operational challenges. They can customize an application using the platform specific to their business use case.

Additionally, AmpleLogic also offers a comprehensive suite of 14 ready-to-use, pre-validated applications designed for regulated industries such as pharmaceuticals manufacturing, biotechnology, medical devices, gene therapy, beauty & cosmetics, food & beverages, and more. These include:

Annual Product Quality Review Software
Quality Management System
Manufacturing Execution System
Electronic Logbook System
Environmental Monitoring System
Document Management System
Learning Management System
Cleaning Validation System
Process Validation System
Stability Management System
Regulatory Information Management System
Laboratory Information Management System
User Access Management System
Calibration and PM Software

"We are excited to launch our new aPaaS platform made for the life sciences industry, designed to streamline operations and ensure compliance," said Mr. Manne V. Chowdhary, CEO & MD of AmpleLogic. "Our platform leverages the latest technologies to provide scalable and flexible solutions that meet the unique needs of our clients in the life sciences sector. With over 100 happy clients spanning 14 years of operations in this field, this is one of AmpleLogic's many endeavors and a step forward in our mission to deliver innovative and effective software solutions."

AmpleLogic also integrates AI and ML for enhanced solutions, offering predictive analysis and automated SOP-based questionnaire generation. Their Learning Management System uses these technologies for targeted training, ensuring compliance and workforce readiness.

About AmpleLogic:

AmpleLogic is a premier provider of cutting-edge technology solutions for the life sciences industry. Focused on delivering high-quality, compliant, and user-friendly platforms, AmpleLogic helps organizations streamline operations, ensure regulatory compliance and drive growth. Serving small biotech firms to large pharmaceutical companies, AmpleLogic meets unique industry needs with its innovative solutions.

For more information, visit www.amplelogic.com.

Logo:

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/amplelogic-launches-advanced-apaas-for-life-sciences-with-14-ready-to-use-applications-302161817.html

Images

Tags

More Like This

AmpleLogic Turns 15; Marked in an Evening Filled with Celebrations and Inspiration

ScienceLogic Named a Leader in AIOps Platform Report

GlobalLogic Announces ‘Platform of Platforms’ for Enabling Enterprise-Grade AI

ScienceLogic Announces “Hollywood” Release of SL1 Platform, Introducing Advanced AI/ML & Automation Capabilities for AIOps

AppLogic Networks Secures Commitment from Leading MSP to Unlock New Revenue Paths with Edge-Ready, AI-Driven QoE Platform

Proactis chooses SnapLogic as its Generative AI integration platform as a service (iPaaS).

ScienceLogic Shares Bold Vision of Autonomic IT to Power the Autonomous Business

LABCONNECT ACQUIRES SCIENTIFIC CONSULTANCY A4P